Article
A Multi-Center Clinical Diagnostic Accuracy Study of Surestatus - an Affordable, WHO Emergency-Use-Listed, Rapid, Point-of-Care, Antigen-Detecting Diagnostic Test for SARS-CoV-2
2022-04-01
Abstract excerpt
Background: Access to RT-PCR testing, the gold standard for SARS-CoV-2 detection, is limited throughout the world, due to restricted resources, available infrastructure, and high costs. Antigen-detecting, rapid diagnostic tests (Ag-RDTs) overcome some of these barriers, but independent clinical validations in settings of intended use are scarce. To inform the World Health Organisation’s (WHO) emergency use listing...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 91a1267a-fafa-5792-88dd-52dde80adc1b
- DOI
- 10.2139/ssrn.4072491
